TFRC and glioblastoma: Antisense miRNA oligonucleotides against miR-21 (AMO-21) with potential for the treatment of glioblastoma were delivered by exosomes decorated with Lamp2b-fused T7 peptide since the transferrin receptor is overexpressed on the surface of glioblastoma cells.